Silicon Valley Bank Results Presentation Deck
Building the premier investment bank dedicated to the innovation economy
SVB Leerink expansion initiatives enhance ability to
deliver strategic support to our clients as they grow
2021 HIGHLIGHTS
Acquired technology equity research firm MoffettNathanson
LLC in December
●
●
●
●
Launched Technology Investment Banking in September
Deepened Healthcare Services and Healthtech Practices
Added Leveraged Finance, Private Placements, SPACs and
Structured Finance capabilities
52 Technology¹ and 50 Healthcare Services and
Healthtech investment bankers hired in 2021
LOOKING AHEAD
-25-50 anticipated additional hires through year-end 2022 to build out
technology equity capital markets, fintech, leveraged finance, sponsor coverageand
equity research
EDUCATION INDUSTRIAL ENTERPRISE
TECHNOLOGY TECHNOLOGY SOFTWARE
svb >
LV
~$150-200M expected SVB Leerink revenue in 2022 from combined new initiatives,
shifting the mix of business towards higher margin advisory fees
NEW
TECHNOLOGY
DIGITAL
INFRA & TECH
SERVICES
DUD
CONSUMER
SOFTWARE,
INTERNET &
INFO SERVICES
FINTECH
ENCES/HEALTHCARE CAPABILITIES
----
$
Alternative
Equities
Institutional
Equities
Convertible
Securities
u
wwwww
TOOLS &
DIAGNOSTICS
Equity
MEDACorp Research
SVBLEERINK
Structured
Finance
SPACS
1. Excludes Moffett Nathanson employees.
2. Included in FY'22 outlook for SVB Leerink revenue of $625-675M. SVB Leerink revenue is a non-GAAP financial
measure. See "Use of non-GAAP Financial Measures" in our Q4 2021 Earnings Release and our non-GAAP
reconciliations at the end of this presentation.
TECHNOLOGY
CAPABILITIES
Equity
Capital
Markets
M&A
Advisory
Leveraged
Finance
Private
Placements
LIFE SCIENCES/HEALTHCARE
MEDICAL
DEVICES
BIOPHARMA HEALTHCARE
SERVICES
ADDED
2021
DIGITAL
HEALTH &
HEALTHTECH
Expanded in 2021
Q4 2021 Financial Highlights
15View entire presentation